Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.84 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.84 |
| ▸ | ALOX5AP | P20292 | 18/20 | 0.82 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2108321 | 0.99 | PTGS1 (0.85) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL9252681 | 0.98 | PTGS1 (0.84) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL2107929 | 0.93 | PTGS1 (0.82) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL2107877 | 0.92 | PTGS1 (0.86) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL8559127 | 0.92 | PTGS1 (0.75) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL9252691 | 0.92 | ALOX5AP (0.78) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL2107740 | 0.92 | PTGS1 (0.85) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL2108907 | 0.92 | PTGS1 (0.87) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL2109203 | 0.92 | PTGS1 (0.85) | PTGS1PTGS2ALOX5APALOX5CYP3A4 | |
| SCHEMBL2108178 | 0.91 | PTGS1 (1.00) | PTGS1PTGS2ALOX5APALOX5CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5380850-A | Quinoline hydrazine intermediates | MERCK FROSST CANADA, INC. (CA) | 1995-01-10 | — | — | US | disclosed |